NUVASIVE UK LIMITED
Get an alert when NUVASIVE UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-09 (in 3mo)
Last made up 2025-07-26
Watchouts
None on the register
Cash
£5M
+54.1% vs 2023
Net assets
£6M
+7.8% vs 2023
Employees
36
-23.4% vs 2023
Profit before tax
£561K
-5.5% vs 2023
Name history
Renamed 1 time since incorporation
- NUVASIVE UK LIMITED 2005-07-29 → present
- NUVASIVE LIMITED 2005-07-26 → 2005-07-29
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £11,176,142 | £14,235,629 | |
| Operating profit | £564,543 | £561,288 | |
| Profit before tax | £593,797 | £561,288 | |
| Net profit | £533,732 | £442,995 | |
| Cash | £3,374,997 | £5,200,692 | |
| Total assets less current liabilities | £5,848,207 | £6,327,096 | |
| Net assets | £5,661,760 | £6,104,755 | |
| Equity | £5,661,760 | £6,104,755 | |
| Average employees | 47 | 36 | |
| Wages | £3,240,754 | £2,941,038 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 5.1% | 3.9% | |
| Net margin | 4.8% | 3.1% | |
| Return on capital employed | 9.7% | 8.9% | |
| Gearing (liabilities / total assets) | 17.2% | 34.1% | |
| Current ratio | 6.93x | 3.16x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PKF Littlejohn LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have assessed the appropriateness of the going concern in relation to these financial statements and consider that it is fair to prepare the accounts on a going concern basis. This conclusion is based on the Company through its cash resources and sufficient assets to meet its liabilities as they fall due for a period of at least 12 months from the date these financial statements are signed.”
Significant events
- “Up to 31 August 2023, the Company's ultimate parent company is NuVasive Inc, a company incorporated in the United States of America. With effect from 1 September 2023, the shareholders approved the merger agreement between NuVasive, Inc. and Globus Medical Inc.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 21 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BURKLOW, Tyler Coleman | Director | 2026-02-17 | Jul 1980 | American |
| KLINE, Kyle Richard | Director | 2025-09-01 | Jan 1985 | American |
Show 21 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HANNON, Jason | Secretary | 2005-08-01 | 2017-08-01 |
| WCPHD SECRETARIES LIMITED | Corporate Secretary | 2005-07-26 | 2005-08-01 |
| ALEXANDER, Darren Eugene | Director | 2021-07-02 | 2024-02-02 |
| BITAR, Patricia Lynn | Director | 2011-12-01 | 2014-03-15 |
| BRADSHAW, Philip Peter | Director | 2015-01-12 | 2015-04-29 |
| HANNON, Jason | Director | 2005-08-01 | 2017-08-01 |
| HANSON, Jason David | Director | 2016-02-01 | 2016-08-01 |
| HUNSAKER, Craig Edward | Director | 2013-03-18 | 2014-03-15 |
| KIIL III, Harry Skip | Director | 2017-09-13 | 2018-10-31 |
| KONING, John Todd | Director | 2017-09-13 | 2018-04-12 |
| LUKIANOV, Alexis V | Director | 2005-08-01 | 2011-06-07 |
| MARZANO, Peter Louis | Director | 2021-07-02 | 2024-01-01 |
| PECORA, Alicia Marie | Director | 2018-07-26 | 2024-02-02 |
| PFEIL, Keith William | Director | 2024-02-02 | 2025-09-02 |
| POWERS, Russell Alan | Director | 2013-03-18 | 2015-10-01 |
| SHIELDS, Dustin S | Director | 2024-02-02 | 2025-11-10 |
| SIEMERS, Stephan | Director | 2012-08-31 | 2012-12-20 |
| VALENTINE, Keith | Director | 2011-06-07 | 2013-03-18 |
| WEDGBURY WEIGHELL, Ian Richard | Director | 2021-04-01 | 2024-02-02 |
| YOUNG, Micah Wesley | Director | 2014-03-15 | 2017-10-03 |
| WCPHD DIRECTORS LIMITED | Corporate Director | 2005-07-26 | 2005-08-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Globus Medical, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-09-01 | Active |
| Nuvasive, Inc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2023-09-01 |
Filing timeline
Last 20 of 119 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-17 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-02-27 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-17 | AA | accounts | Accounts with accounts type full | |
| 2025-11-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-03 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-09-26 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-09-02 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-02 | AP01 | officers | Appoint person director company with name date | |
| 2025-08-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-13 | AA | accounts | Accounts with accounts type full | |
| 2024-08-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-06 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-02-15 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-14 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-14 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-14 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-14 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-12 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-05 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-08-23 | AA | accounts | Accounts with accounts type small |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+27.4%
£11,176,142 £14,235,629
-
Cash
+54.1%
£3,374,997 £5,200,692
-
Net assets
+7.8%
£5,661,760 £6,104,755
-
Employees
-23.4%
47 36
-
Operating profit
-0.6%
£564,543 £561,288
-
Profit before tax
-5.5%
£593,797 £561,288
-
Wages
-9.2%
£3,240,754 £2,941,038
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers